Does Aromatherapy Decrease Postoperative Nausea and Vomiting?

Sponsor
The University of Texas Medical Branch, Galveston (Other)
Overall Status
Completed
CT.gov ID
NCT03577496
Collaborator
(none)
50
1
1
6
8.3

Study Details

Study Description

Brief Summary

Aromatherapy has been proven to be effective for treating patients with postoperative nausea and vomiting (PONV) after surgery, but few studies analyze its effect on preventing PONV. Most studies use aromatherapy once patients become nauseous, but this study will address a gap in the literature with relation to the effect of aromatherapy in the prevention of PONV.

Condition or Disease Intervention/Treatment Phase
  • Other: Peppermint oil
N/A

Detailed Description

The purpose of this pilot study is to determine if aromatherapy will prevent postoperative nausea and vomiting (PONV). Peppermint aromatherapy will be used preemptively to test for effectiveness, decreased PONV, and the ability to avoid anti-emetics. This study will seek to demonstrate that peppermint aromatherapy is a simple, cost effective way to prevent PONV after anesthesia. By decreasing the need for anti-emetics and incidence of PONV, patients may have a quicker recovery time and experience less side effects from anti-emetics, such as increased sedation. This problem is significant to patients and society as it may demonstrate that the inhalation of peppermint can ease PONV and decrease costs due to anti-emetics, wound dehiscence, and prolonged hospital stay. This study may lead to higher levels of patient satisfaction; if the patients are not nauseated they may be more satisfied with their care.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Does Aromatherapy Decrease Postoperative Nausea and Vomiting?
Actual Study Start Date :
Jun 15, 2018
Actual Primary Completion Date :
Dec 15, 2018
Actual Study Completion Date :
Dec 15, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Peppermint oil

A cotton ball with three drops of peppermint oil will be waved under the patient's nares upon arrival to the recovery room. The patients will be assessed for PONV for up to an hour in the post anesthesia care unit (PACU) or until their discharge, whichever is first.

Other: Peppermint oil
A cotton ball with three drops of peppermint oil will be waved under the patient's nares.

Outcome Measures

Primary Outcome Measures

  1. Decrease incidence of postoperative nausea and vomiting (PONV) [Patients will be monitored for up to one hour after surgery to test effectiveness of peppermint oil at decreasing PONV.]

    Decreased severity of PONV rating with peppermint aromatherapy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult surgical patients ages 18 and older.

  • Patients deemed medically stable by their surgery team.

  • Anesthesia and Surgeon faculty approval will be obtained prior to asking the patient for their consent.

Exclusion Criteria:
  • Minors

  • Unstable patients, such as ICU patients or intubated patients, pregnant women, and prisoners.

  • Patients with a history of severe PONV or severe delirium on emergence from anesthesia will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Texas Medical Branch Galveston Texas United States 77555

Sponsors and Collaborators

  • The University of Texas Medical Branch, Galveston

Investigators

  • Principal Investigator: Michelle S Karsten, RN, BSN, University of Texas

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The University of Texas Medical Branch, Galveston
ClinicalTrials.gov Identifier:
NCT03577496
Other Study ID Numbers:
  • 18-0058
First Posted:
Jul 5, 2018
Last Update Posted:
Jan 9, 2019
Last Verified:
Jun 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 9, 2019